Eli Lilly and Company (LLY)
Debt-to-assets ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 18,320,800 | 14,737,500 | 15,346,400 | 16,586,600 | 13,817,900 |
Total assets | US$ in thousands | 64,006,300 | 49,489,800 | 48,806,000 | 46,633,100 | 39,286,100 |
Debt-to-assets ratio | 0.29 | 0.30 | 0.31 | 0.36 | 0.35 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $18,320,800K ÷ $64,006,300K
= 0.29
The debt-to-assets ratio of Lilly(Eli) & Co has exhibited fluctuations over the past five years, as follows: 0.39 in 2023, 0.33 in 2022, 0.35 in 2021, 0.36 in 2020, and 0.39 in 2019. This ratio indicates the proportion of the company's assets financed through debt. A lower ratio suggests lower financial risk as there is less reliance on debt for financing assets. Conversely, a higher ratio may signal higher financial risk due to increased debt levels.
Lilly(Eli) & Co's debt-to-assets ratio has generally been within a moderate range over the years, typically ranging from 0.33 to 0.39. The increase in the ratio from 0.33 in 2022 to 0.39 in 2023 may indicate a higher dependency on debt for asset financing, which could potentially increase financial risks. It is important for stakeholders to closely monitor the trend in this ratio to assess the company's financial health and risk levels associated with its debt structure.
Peer comparison
Dec 31, 2023